Suma Krishnan, President, R&D at Krystal Biotech, Inc. (KRYS), sold 80,416 shares at $116.95 ($9.3M) on 2023-05-31, disclosed to the SEC on 2023-06-02.
Open-market sale of $9.3M KRYS by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $115.98 | 20,143 | $2.3M | 25.0% |
| 2 | $115.98 | 20,143 | $2.3M | 25.0% |
| 3 | $116.00 | 18,884 | $2.2M | 23.4% |
| 4 | $116.86 | 4,557 | $533K | 5.7% |
| 5 | $116.86 | 4,557 | $533K | 5.7% |
| 6 | $116.95 | 5,716 |
| $668K |
| 7.2% |
| 7 | $116.95 | 5,716 | $668K | 7.2% |
| 8 | $117.57 | 300 | $35K | 0.4% |
| 9 | $117.61 | 400 | $47K | 0.5% |
| Total | $116.24 avg | 80,416 | $9.3M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |